-
Management Board: Highlights of June 2023 meetingManagement Board |Highlights
Management Board: Highlights of June 2023 meeting
-
Management Board: Highlights of June 2023 meetingManagement Board |Highlights
Management Board: Highlights of June 2023 meeting
The Board adopted the Executive Director’s annual activity report for 2022 and was updated on recent initiatives on clinical trials in the EU
-
Highlights of the Safety Committee: June 2023MEDICINES |COMMITTEES
Highlights of the Safety Committee: June 2023
-
Highlights of the Safety Committee: June 2023MEDICINES |COMMITTEES
Highlights of the Safety Committee: June 2023
At its monthly meeting, EMA's safety committee, the PRAC, carried out its work to assess all aspects of risk management related to the use of medicines
-
EMA-ECDC updates on adapted COVID-19 vaccinesCOVID-19 |vaccines
EMA-ECDC updates on adapted COVID-19 vaccines
-
EMA-ECDC updates on adapted COVID-19 vaccinesCOVID-19 |vaccines
EMA-ECDC updates on adapted COVID-19 vaccines
The European Centre for Disease Prevention and Control (ECDC) and EMA have issued a joint statement on adapted COVID-19 vaccines and their use in autumn vaccination campaigns
-
Adapting COVID-19 vaccines to future variantsCOVID-19 |International collaboration
Adapting COVID-19 vaccines to future variants
-
Adapting COVID-19 vaccines to future variantsCOVID-19 |International collaboration
Adapting COVID-19 vaccines to future variants
Global regulators agreed on a way forward to adapt COVID-19 vaccines to future variants, during a workshop co-chaired by EMA and the FDA, under the umbrella of ICMRA
Latest news
-
List item09/06/2023
EMA Management Board: highlights of June 2023 meeting
EMA’s Management Board met on 7-8 June in Amsterdam. The European Commission informed the Board about its legal proposals to revise the pharmaceutical legislation, published on 26 April, which aim to make the EU regulatory framework fit for...
-
List item09/06/2023
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 5 - 8 June 2023
At its monthly meeting, EMA’s safety committee (PRAC) carried out its broad range of responsibilities, which cover all aspects of the risk management of the use of medicines: assessment of safety signals, risk management plans, periodic safety...
-
List item06/06/2023 COVID-19
EMA and ECDC statement on updating COVID-19 vaccines to target new SARS-CoV-2 virus variants
The European Centre for Disease Prevention and Control (ECDC) and the European Medicines Agency (EMA) have issued a joint statement on adapted COVID-19 vaccines and considerations for their use during the upcoming autumn 2023 vaccination campaigns...
-
List item31/05/2023
Progress with EU-US mutual recognition agreement for inspections for veterinary medicines
Today, the European Union (EU) and the United States (US) have made important progress towards enabling mutual recognition of inspections of manufacturing facilities of certain veterinary products. The Food and Drug Administration (FDA) has...
-
List item30/05/2023 COVID-19
Global regulators agree on way forward to adapt COVID-19 vaccines to emerging variants
International regulators have published a report today highlighting the outcomes of their discussions on COVID-19 vaccines and the need for and strategy to update their composition based on the emerging evidence on coronavirus SARS-CoV-2 variants...
-
List item26/05/2023
EMA business hours over Whit Monday, 29 May
The European Medicines Agency's (EMA) office is closed on Monday 29 May 2023. Outside of working hours and on public holidays, it is possible to call the product emergency hotline on +31(0)88 781 7600. Please note that this is an emergency number...
Information for you






Key content
Services & databases
-
List item
Clinical Trials website
-
List item
Account Management portal
-
List item
eSubmission
-
List item
EudraVigilance (human)
-
List item
EudraVigilance Veterinary
-
List item
Veterinary Medicines information website
-
List item
Suspected adverse drug reactions database
-
List item
Clinical data
-
List item
SPOR data management services
-
List item
Service Desk
-
List item
IRIS platform
-
List item
Public register of parallel distribution notices
-
List item
European Vaccination Information Portal